Age Restriction Update for Beremagene Geperpavec-Svdt (Vyjuvek) Procedure Code J3401
Effective date
Mar 1, 2026
Identified
Jan 24, 2026
Summary
Effective March 1, 2026, the FDA has approved age expansion for beremagene geperpavec-svdt (Vyjuvek) procedure code J3401 to include adult and pediatric clients of all ages, removing previous age restrictions. This change applies to Texas Medicaid and managed care organizations must provide this medically necessary service to enrolled members.
Get alerts when payers change rules like this one
We check Texas Medicaid and other payers every day and email you when a change matches your specialty and state.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.